United States of America v. St. Mark's Hospital

District Court, D. Utah·Decided June 3, 2020·No. 2:16-cv-00304·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF UTAH

UNITED STATES OF AMERICA, ex rel. GERALD POLUKOFF, M.D., MEMORANDUM DECISION AND Plaintiff/Relator, ORDER DENYING DEFENDANTS’ MOTION TO EXCLUDE EXPERTS AND v. MOTION TO STRIKE EXPERT REPORTS

ST. MARK’S HOSPITAL; INTERMOUNTAIN HEALTHCARE, INC.; INTERMOUNTAIN MEDICAL CENTER; SHERMAN SORENSEN, M.D.; Case No. 2:16-CV-304 TS and SORENSEN CARDIOVASCULAR GROUP, District Judge Ted Stewart

Defendants.

This matter is before the Court on Sherman Sorensen, M.D. and Sorensen Cardiovascular Group’s (collectively, “Defendants”) Motion to Exclude Experts1 and Motion to Strike Expert Reports.2 These motions seek to exclude proposed expert witnesses retained by Plaintiff/Relator Gerald Polukoff, M.D. (“Relator”) and their reports submitted to Defendants pursuant to discovery.3 For the reasons discussed below, the Court will deny both motions. I. BACKGROUND This case commenced on December 6, 2012, when Relator filed a qui tam action, alleging that Defendants performed medically unnecessary patent foramen ovale (“PFO”) and/or atrial septal defect (“ASD”) closures, fraudulently collecting payment from the United States Government in violation of the False Claims Act, 31 U.S.C. §§ 3729–32.4 The December 3,

1 Docket No. 296. 2 Docket No. 297. 3 See Docket Nos. 296, 296-1, 297, 297-1, 297-2, 297-3, 297-4, 297-5. 4 See Docket No. 1. 2015 Amended Complaint later replaced the initial complaint.5 On December 19, 2018, this Court held a Scheduling Conference and received parties’ input on how to proceed.6 On March 20, 2019, Defendants, together with other defendant parties, submitted a Joint Statement of Issues in Advance of March 28 Hearing (“Joint Statement”).7 In this Joint Statement,

Defendants argued that discovery should occur in phases, with the first phase focusing on whether claims submitted to the government were “‘false,’ in that the procedures were not medically necessary.”8 On March 22, 2019, Relator submitted a Status Report and Proposed Scheduling Order objecting to phased discovery.9 He argued that this case is not complex enough to justify phased discovery10 and asked that discovery “be scheduled like an ordinary case.”11 In its April 8, 2019 Scheduling Order, this Court set forth a phased discovery schedule, with expert reports regarding the issue of “Standard of Care/Medical Necessity of PFO/ASD Closures in the Medical Community” due first, and expert reports on “all other topics” due about a year later.12 The Amended Scheduling Order entered on September 13, 2019, updated the first discovery deadline to be November 15, 2019,13 and left the expert discovery deadline for “all other topics” unchanged as September 29, 2020.14 Neither party filed objections to this

schedule.

5 See Docket No. 90. 6 See Docket No. 239. 7 Docket No. 258. 8 See id. at 2. 9 Docket No. 260. 10 See Docket No. 260, at 3–9; 260-1. 11 Docket No. 260, at 4. 12 See Docket No. 262, at 3. 13 See Docket No. 291, at 1. 14 See Docket No. 262, at 3. On October 3, 2019, before the initial discovery deadline arrived, Defendants filed both their Motion to Exclude Experts and Motion to Strike Expert Reports.15 Relator filed his Amended Combined Response to the Motion to Exclude Experts and Motion to Strike Expert Reports on October 18, 2019.16 Defendants filed their Reply to the Combined Reponses on October 31, 2019.17 On November 18, 2019, Relator submitted exhibit materials18 that

supplemented statements from his proposed experts in the Amended Response.19 In light of these new materials, Defendants filed their Amended Replies on November 27, 2019.20 II. STANDARD OF REVIEW Concerning the admissibility of expert opinion, Federal Rule of Evidence 702 states that: A witness who is qualified as an expert by knowledge, skill, experience, training, or education may testify in the form of an opinion or otherwise if: (a) the expert’s scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case.21

15 Docket Nos. 296, 297. 16 Docket No. 320. 17 Docket No. 334. 18 Docket No. 349. 19 Docket No. 320. 20 Docket Nos. 359, 360. 21 FED. R. EVID. 702. Although the standard under Rule 702 is “liberal . . . regarding expert qualifications,”22 “[t]he proponent of expert testimony bears the burden of showing that the testimony is admissible.”23 Rule 702 “imposes upon the trial judge an important ‘gate-keeping’ function with regard to the admissibility of expert opinions.”24 This involves a two-step analysis.25 The district court

“must first determine whether the expert is qualified ‘by knowledge, skill, experience, training, or education’ to render an opinion.”26 Preliminary questions concerning the qualification of a person to be a witness should be established by a preponderance of proof.27 Second, “the court must determine whether the expert’s opinion is reliable by assessing the underlying reasoning and methodology, as set forth in Daubert.”28 “Under Rule 702, a district court must satisfy itself that the proposed expert testimony is both reliable and relevant, in that it will assist the trier of fact, before permitting a jury to assess such testimony.”29 However, “[a]t the Rule 702 gatekeeping stage, district courts must avoid weighing the credibility or persuasiveness of the competing experts’ ultimate conclusions.”30

22 Fowers Fruit Ranch, LLC v. Bio Tech Nutrients, LLC, No. 2:11-CV-105-TC, 2015 WL 2201715, at *1 (D. Utah May 11, 2015) (quoting United States v. Gomez, 67 F.3d 1515, 1526 (10th Cir. 1995)). 23 Id. (quoting Conroy v. Vilsack, 707 F.3d 1163, 1168 (10th Cir. 2013)) (alteration in original). 24 Mathis v. Huff & Puff Trucking, Inc., 787 F.3d 1297, 1307 (10th Cir. 2015) (quoting Ralston v. Smith & Nephew Richards Inc., 275 F.3d 965, 969 (10th Cir. 2001)); see generally Daubert v. Merrell Dow Pharm. Inc., 509 U.S. 579 (1993). 25 See United States v. Nacchio, 555 F.3d 1234, 1241 (10th Cir. 2009) (en banc). 26 Id. (quoting FED. R. EVID. 702). 27 Daubert, 509 U.S. at 592 n.10. 28 Nacchio, 555 F.3d at 1241 (citing United States v. Rodriguez–Felix, 450 F. 3d 1117, 1123 (10th Cir. 2006)). 29 Rodriguez–Felix, 450 F. 3d at 1122–23 (citing FED. R. EVID. 702). 30 Heer v. Costco Wholesale Corp., 589 F. App’x. 854, 862 (10th Cir. 2014) (internal citations omitted). III. DISCUSSION Defendants’ Motion to Exclude Experts seeks to exclude four of Relator’s five proposed experts—Dr. Michael J. Diehl, Dr. Alan Richard Maniet, Jr., Dr. Richard Weiss, and Dr. Lawrence Baruch, the four cardiologists.31 It does not seek to exclude Dr. Nancy Futrell, a neurologist.32 It addresses prong one of Rule 702 regarding qualifications of expert witnesses.

Free access — add to your briefcase to read the full text and ask questions with AI

United States of America v. St. Mark's Hospital, (D. Utah 2020).

United States of America v. St. Mark's Hospital (United States of America v. St. Mark's Hospital) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Mitchell v. Gencorp Inc.
165 F.3d 778 (Tenth Circuit, 1999)
United States v. Oliver
278 F.3d 1035 (Tenth Circuit, 2001)
Ralston v. Smith & Nephew Richards, Inc.
275 F.3d 965 (Tenth Circuit, 2001)
United States v. Rodriguez-Felix
450 F.3d 1117 (Tenth Circuit, 2006)
United States v. Lupe Gomez
67 F.3d 1515 (Tenth Circuit, 1995)
Conroy v. Vilsack
707 F.3d 1163 (Tenth Circuit, 2013)
United States v. Nacchio
555 F.3d 1234 (Tenth Circuit, 2009)
Mathis v. Huff & Puff Trucking, Inc.
787 F.3d 1297 (Tenth Circuit, 2015)
United States Ex Rel. Polukoff v. St. Mark's Hosp.
895 F.3d 730 (Tenth Circuit, 2018)